Cancer News
OncoLink Cancer News - HealthDay


Low Adherence Rates for Prostate Cancer Quality of Care Measures

Monday, April 21, 2014 (Last Updated: 04/22/2014)

MONDAY, April 21, 2014 (HealthDay News) -- Adherence to established prostate cancer quality of care measures is frequently low, with considerable regional variation, according to a study published in the April issue of The Journal of Urology.

Florian R. Schroeck, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a retrospective study to examine regional variation in adherence to quality measures for 53,614 patients with newly diagnosed prostate cancer. Patients were identified from Surveillance, Epidemiology, and End Results-Medicare data for 2001 to 2007, and were assigned to 661 regions.

The researchers observed extensive patient-level variation in adherence, varying from 33 percent for treatment by a high-volume provider to 76 percent for adjuvant androgen deprivation therapy receipt while undergoing radiation for high-risk cancer. Considerable regional variation was observed in adherence to several measures, including pretherapy counseling by a urologist and radiation oncologist, which ranged from 9 to 89 percent; avoiding bone scan overuse in low-risk cancer, which ranged from 16 to 96 percent; treatment by a high-volume provider, which ranged from 1 to 90 percent; and follow-up with a radiation oncologist, which varied from 14 to 86 percent (all P < 0.001).

"We found low adherence rates for most established prostate cancer quality of care measures. Within most measures regional variation in adherence was pronounced," the authors write. "Measures with low adherence and a large amount of regional variation may be important low hanging targets for quality improvement."

One author disclosed financial ties to Amgen; one author disclosed financial ties to Elsevier.

Abstract
Full Text

Specialties Hematology & Oncology
Internal Medicine
Nursing
Radiology
Urology
Geriatrics
Family Practice

Copyright © 2014 HealthDay. All rights reserved.


I Wish You Knew

Understanding prostate cancer screening

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More